Results 81 to 90 of about 42,840 (198)

Immune Checkpoint Inhibitors and Cardiovascular Adverse Events

ESC Heart Failure, EarlyView.
Abstract In the last years, we assisted to a tremendous increase in therapeutic options for the management of cancers, with immunotherapy at the forefront of this innovation. Immune checkpoint inhibitors (ICIs) have been developed to enhance the activity of the immune system against cancer cells (1) and the number of approvals for ICIs has rapidly ...
Maria Luisa De Perna, Elia Rigamonti, Raffaele Zannoni, Vittoria Espeli, Giorgio Moschovitis   +4 more
wiley   +1 more source

Relationship Between Human Atrial Natriuretic Peptide and Tricuspid Valve Annular Dilatation in Patients With Atrial Fibrillation. [PDF]

Echocardiography
Izumi K, Utsunomiya H, Tohgi K, Takeuchi M, Hamada A, Hyodo Y, Tsuchiya A, Mogami A, Ueda Y, Takahari K, Nakano Y.   +10 more
europepmc   +1 more source

Pleiotropic Roles of Atrial Natriuretic Peptide in Anti-Inflammation and Anti-Cancer Activity. [PDF]

Cancers (Basel), 2022
Fu H, Zhang J, Cai Q, He Y, Yang D.
europepmc   +1 more source

Congestion, decongestion, renal function and diuretics in (ESC) heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 730-732, April 2025.
Jan Biegus, Piort Gajewski, Piotr Ponikowski   +2 more
wiley   +1 more source

Plasma metabolomics identifies signatures that distinguish heart failure with reduced and preserved ejection fraction

ESC Heart Failure, EarlyView.
Abstract Aims Two general phenotypes of heart failure (HF) are recognized: HF with reduced ejection fraction (HFrEF) and with preserved EF (HFpEF). To develop phenotype‐specific approaches to treatment, distinguishing biomarkers are needed. The goal of this study was to utilize quantitative metabolomics on a large, diverse population to replicate and ...
Fawaz Naeem, Teresa C. Leone, Christopher Petucci, Clarissa Shoffler, Ravindra C. Kodihalli, Tiffany Hidalgo, Cheryl Tow‐Keogh, Jessica Mancuso, Iphigenia Tzameli, Donald Bennett, John D. Groarke, Rachel J. Roth Flach, Daniel J. Rader, Daniel P. Kelly   +13 more
wiley   +1 more source

Inhibiting atrial natriuretic peptide clearance reduces myocardial fibrosis and improves cardiac function in diabetic rats. [PDF]

Eur Heart J Open
Bakhos JJ, Saliba Y, Hajal J, Achkouty G, Oskaridjian H, Albuquerque M, Azevedo C, Semaan A, Suffee N, Balse E, Hatem SN, Fares N.   +11 more
europepmc   +1 more source

Neuroendocrine hormone status and diuretic response to atrial natriuretic peptide in patients with acute heart failure. [PDF]

ESC Heart Fail, 2022
Matsumoto S, Nakamura N, Konishi M, Shibata A, Kida K, Ishii S, Ikeda T, Ikari Y.   +7 more
europepmc   +1 more source

Early prescription of quadruple therapy in acute decompensated heart failure with reduced ejection fraction: A propensity score‐matched analysis

ESC Heart Failure, EarlyView.
This propensity score‐matched analysis of 2051 acute decompensated heart failure patients from the ICARUS registry compared 898 patients who received early quadruple guideline‐directed medical therapy (within 48 h of admission) to 1153 matched controls.
Luis E. Echeverría, Lyda Z. Rojas, Angie Yarlady Serrano‐García, Daniel Botero, Karen Andrea García‐Rueda, Ángela Torres‐Bustamante, Diana Ivonne Cañón‐Gómez, Juan Sebastián Salcedo, Alexandra Hurtado‐Ortiz, Jaime A. Rodríguez, Sergio A. Gómez‐Ochoa   +10 more
wiley   +1 more source

Cardiac corin and atrial natriuretic peptide regulate liver glycogen metabolism and glucose homeostasis. [PDF]

Cardiovasc Diabetol
Li W, Zhang X, Zhou Z, Guo W, Wang M, Zhou T, Liu M, Wu Q, Dong N.   +8 more
europepmc   +1 more source

Midregional Pro-Atrial Natriuretic Peptide and Atrial Fibrillation: Interesting Association or Practice Changing? [PDF]

J Am Coll Cardiol, 2022
Piccini JP, Harrington J.
europepmc   +1 more source